S&P 500
(0.05%) 5 251.33 points
Dow J
(0.02%) 39 766 points
Nasdaq
(-0.12%) 16 380 points
Oil
(1.99%) $82.97
Gas
(1.51%) $1.744
Gold
(1.22%) $2 239.70
Silver
(0.75%) $24.94
Platinum
(1.28%) $921.35
USD/EUR
(0.30%) $0.926
USD/NOK
(0.76%) $10.85
USD/GBP
(0.10%) $0.792
USD/RUB
(0.14%) $92.57

Realtime updates for Egetis Therapeutics AB [EGTX.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 07:59

1.21% SEK 6.68

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 07:59):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Egetis Therapeutics AB (publ), a pharmaceutical drug development company, focuses on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment...

Stats
Today's Volume 101 307
Average Volume 345 228
Market Cap 1.95B
EPS SEK0 ( 2024-02-21 )
Next earnings date ( SEK-0.310 ) 2024-05-02
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -4.77
ATR14 SEK0.0180 (0.27%)

Volume Correlation

Long: 0.12 (neutral)
Short: 0.02 (neutral)
Signal:(51.884) Neutral

Egetis Therapeutics AB Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Egetis Therapeutics AB Correlation - Currency/Commodity

The country flag 0.27
( neutral )
The country flag 0.27
( neutral )
The country flag 0.00
( neutral )
The country flag 0.13
( neutral )
The country flag -0.19
( neutral )
The country flag -0.33
( neutral )

Egetis Therapeutics AB Financials

Annual 2023
Revenue: SEK57.60M
Gross Profit: SEK-126.80M (-220.14 %)
EPS: SEK-1.270
Q4 2023
Revenue: SEK32.60M
Gross Profit: SEK-29.70M (-91.10 %)
EPS: SEK-0.300
Q3 2023
Revenue: SEK12.20M
Gross Profit: SEK-41.70M (-341.80 %)
EPS: SEK-0.350
Q2 2023
Revenue: SEK5.90M
Gross Profit: SEK-36.90M (-625.42 %)
EPS: SEK-0.320

Financial Reports:

No articles found.

Egetis Therapeutics AB

Egetis Therapeutics AB (publ), a pharmaceutical drug development company, focuses on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment. Its products pipeline includes Aladote, a drug to reduce the risk of acute liver injury associated with acetaminophen/paracetamol poisoning, which is in phase IIb/III clinical trial; and Emcitate, a drug for the treatment of MCT8 deficiency, a rare inborn error of thyroid hormone signaling that is in phase IIb/III clinical trial. The company was formerly known as PledPharma AB (publ) and changed its name to Egetis Therapeutics AB (publ) in December 2020. Egetis Therapeutics AB (publ) was incorporated in 2006 and is based in Stockholm, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators